YiPSCELL
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $11M
Investors
- 4
About YiPSCELL
, Ltd. is a company based on induced multifunctional stem cell technology that provides disease modeling services. In March 2010, the company established the CiSTEM Research Laboratory. The company has obtained more than five patents. The company uses induced multifunctional stem cell technology to develop therapeutic agents that are effective for patients and to provide researchers with a research platform. The company also develops stem cell-based therapeutic agents. The research of the company include MIUChon™, MIUKin™, MIURon™, MIUHeart™, MIUBon™, and Exosome™. The company also provides cell line service and analysis service.
Who invested in YiPSCELL
4 investors across 1 round
See all investors in YiPSCELL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 7, 2021
Amount
$11M
Investors
Questions about YiPSCELL
Who invested in YiPSCELL?
YiPSCELL has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has YiPSCELL raised?
YiPSCELL has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did YiPSCELL last raise money?
YiPSCELL's most recent round on record is a Series A, in Jun 2021.
What does YiPSCELL do?
YiPSCELL is a pharmaceuticals company.
Where is YiPSCELL headquartered?
YiPSCELL is headquartered in Seoul, South Korea.
Which VCs invest in companies like YiPSCELL?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at YiPSCELL's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like YiPSCELL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.